Looking to possible predictive factors of primary resistance to abiraterone acetate (AA) and enzalutamide (ENZ) in pretreated patients (pts) with castration-resistant prostate cancer (CRPC).
Orazio Caffo
No relevant relationships to disclose
Antonello Veccia
No relevant relationships to disclose
Francesca Maines
No relevant relationships to disclose
Alberto Bonetta
No relevant relationships to disclose
Gilbert Spizzo
No relevant relationships to disclose
Enzo Galligioni
No relevant relationships to disclose